Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medicines Co (NASDAQ:MDCO)

35.50
Delayed Data
As of Aug 18
 +0.10 / +0.28%
Today’s Change
30.80
Today|||52-Week Range
55.95
+4.60%
Year-to-Date
Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak
Aug 15 / Zacks.com - Paid Partner Content
The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss
Aug 10 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss
Aug 10 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak
Aug 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.40
Today’s open35.40
Day’s range34.97 - 35.79
Volume775,467
Average volume (3 months)1,229,500
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+67.46%
Earnings growth (this year)-476.89%
Earnings growth (next 5 years)+72.90%
Revenue growth (last year)-45.69%
P/E ratioNM
Price/Sales14.14
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-0.11-0.11%
GWPHGW Pharmaceuticals P...-1.59-1.57%
LGNDLigand Pharmaceutica...-0.36-0.28%
AGIOAgios Pharmaceutical...+0.20+0.36%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)-$1.32
Annual revenue (last year)$167.8M
Annual profit (last year)-$120.1M
Net profit margin-71.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Clive A. Meanwell
President &
Chief Operating Officer
Tony Kingsley
Corporate headquarters
Parsippany, New Jersey

Forecasts